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Somatostatin receptor 2AIn order to understand how nociceptive information is processed in the spinal dorsal horn we need to
unravel the complex synaptic circuits involving interneurons, which constitute the vast majority of the
neurons in laminae I–III. The main limitation has been the difﬁculty in deﬁning functional populations
among these cells. We have recently identiﬁed 4 non-overlapping classes of inhibitory interneuron,
deﬁned by expression of galanin, neuropeptide Y (NPY), neuronal nitric oxide synthase (nNOS) and par-
valbumin, in the rat spinal cord. In this study we demonstrate that these form distinct functional popu-
lations that differ in terms of sst2A receptor expression and in their responses to painful stimulation. The
sst2A receptor was expressed by nearly all of the nNOS- and galanin-containing inhibitory interneurons
but by few of those with NPY and none of the parvalbumin cells. Many galanin- and NPY-containing cells
exhibited phosphorylated extracellular signal-regulated kinases (pERK) after mechanical, thermal or
chemical noxious stimuli, but very few nNOS-containing cells expressed pERK after any of these
stimuli. However, many nNOS-positive inhibitory interneurons up-regulated Fos after noxious thermal
stimulation or injection of formalin, but not after capsaicin injection. Parvalbumin cells did not
express either activity-dependent marker following any of these stimuli. These results suggest that
interneurons belonging to the NPY, nNOS and galanin populations are involved in attenuating pain,
and for NPY and nNOS cells this is likely to result from direct inhibition of nociceptive projection
neurons. They also suggest that the nociceptive inputs to the nNOS cells differ from those to the galanin
and NPY populations.
 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1. Introduction
The great majority of neurons in laminae I–III of the dorsal horn
are interneurons with axons that arborize locally, and these play a
major part in the neuronal circuits that process sensory inputs,
including those perceived as pain [2,11,37,52,60,66,77,80]. Our
understanding of the organisation of these circuits remains limited,
mainly as a result of the difﬁculty of deﬁning functional popula-
tions among the interneurons [11,66,80]. Inhibitory interneurons
that use GABA and/or glycine constitute 25–40% of the neurons
in laminae I–III in the rat [45]. Several roles have been suggested
for these cells, including prevention of different types of pain[52,60,77] and suppression of itch [50]. In addition, loss of function
of the inhibitory interneurons (eg, as a result of the decreased syn-
thesis of GABA or reduction of its postsynaptic action) may contrib-
ute to neuropathic pain [6,7,39,44,56]. Previous attempts to
classify dorsal horn interneurons on the basis of morphological
and electrophysiological criteria have met with limited success.
Although some inhibitory interneurons in lamina II have been
identiﬁed as islet or central cells [12,15,16,32,36,67,79,81], many
do not belong to these classes and are morphologically diverse
[16,36,79]. Even less is known about inhibitory interneurons in
laminae I and III.
Neurochemistry provides an alternative approach for classify-
ing these cells, and we have identiﬁed 4 non-overlapping popula-
tions of inhibitory interneurons in laminae I–III of the rat, based
on expression of neuropeptide Y (NPY), galanin, neuronal nitric
oxide synthase (nNOS) or parvalbumin [28,46,54,64]. Between
them, these account for at least half of the inhibitory interneurons
in laminae I–II [54], and it has been demonstrated that there are
Table 1
Antibodies used.
Antibody Species Dilution Source
Galanin Rabbit 1:1,000
1:20,000a
Bachem
NPY Rabbit 1:1,000
1:100,000a
Bachem
nNOS Sheep 1:2,000 P.C. Emson
Parvalbumin Rabbit 1:500 M. Watanabe
Parvalbumin Guinea pig 1:2,500 M. Watanabe
sst2A Guinea pig 1:2,000 Gramsch Laboratories
GABA Rabbit 1:5,000 D.V. Pow
NeuN Mouse 1:500 Millipore
pERK Mouse 1:500 Santa Cruz Biotechnology
Fos Rabbit 1:5,000
1:40,000a
Santa Cruz Biotechnology
a
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[21,46,47,49,54]. Developmental studies also indicate a different
lineage for NPY- and galanin-containing cells in the mouse [4].
The somatostatin receptor sst2A, which is present at high levels
in the superﬁcial dorsal horn [55,57,70], is restricted to inhibitory
interneurons in this region and contributes to disinhibition in the
spinal cord [70,79,80]. Because it is found on 13–15% of neurons
in laminae I–II [70], we estimate that around half of the inhibitory
interneurons in these laminae possess the receptor. However, we
do not yet know whether it is associated with particular neuro-
chemical types of interneuron. Some inhibitory interneurons are
activated by painful stimuli [15,19,69,83,84], but little is known
about the responses of cells belonging to these 4 classes. There is
controversy over the extent to which nNOS-containing neurons
are activated by noxious stimuli [5,18,29,31,41], and there have
apparently been no studies of the responses of cells belonging to
the other 3 populations.
In this study, we examined sst2A expression among the different
neurochemical classes and used 2 different activity-dependent
markers, phosphorylation of extracellular signal–regulated kinases
(ERKs) [23] and expression of Fos [22], to test their responses to
noxious mechanical, thermal and chemical stimuli. The aim was
to determine whether inhibitory interneurons belonging to these
classes differ in their expression of sst2A receptor and their re-
sponses to noxious stimuli, as this would support the idea that
they represent functionally distinct populations and help to eluci-
date their roles in somatosensory processing.
2. Methods
2.1. Animals and tissue processing
Experiments were approved by the Ethical Review Process
Applications Panel of the University of Glasgow and were per-
formed in accordance with the UK Animals (Scientiﬁc Procedures)
Act 1986.
Thirty-seven male Wistar rats (220–350 g; Harlan) were used in
the study. Seven of these were deeply anaesthetized with pento-
barbitone (300 mg i.p.) and perfused through the left ventricle with
ﬁxative. For 4 of the rats this contained 4% freshly depolymerized
formaldehyde, while for the other 3 it contained 4% formalde-
hyde/0.2% glutaraldehyde. The other 30 rats were used to investi-
gate phosphorylation of ERK or expression of Fos after noxious
stimulation. Four different types of noxious stimulus (heat, pinch,
or injection of capsaicin or formalin) were applied to one hind
paw of these animals. For most phospho-ERK (pERK) experiments
(n = 4–6 rats per stimulus type) the stimuli were applied while
the animals were under general anaesthesia with urethane (0.4–
0.8 g, i.p.), and this was maintained for 5 min after the end of the
stimulus, at which point the animals were perfused with ﬁxative
(containing 4% formaldehyde). For Fos experiments (n = 3 rats per
stimulus type), the animals were brieﬂy anaesthetized with isoﬂu-
rane (2.5–3%) while the stimulus was applied and were then al-
lowed to recover from general anaesthesia. They were
reanaesthetized with pentobarbitone and perfused with ﬁxative
(4% formaldehyde) 2 h after the stimulus. The heat stimulus in-
volved immersion of the hind paw in water at 52C for 20 s, while
the pinch stimulus consisted of repeated pinching of folds of skin
(6 each on the dorsal and ventral surface of the hind paw, applied
with forceps for 5 s at each point over the course of 1 min) [42].
Chemical stimulation involved injection of 25 lL of 1% capsaicin
(dissolved in 7% Tween-80, 20% ethanol, saline) [63] or 100 lL of
formalin (2% formaldehyde) [8] into the plantar surface of the
paw. In preliminary experiments we found that relatively few cells
in the superﬁcial dorsal horn were positive for Fos after the pinchstimulus, and this stimulus was therefore not used to investigate
Fos expression. The noxious stimuli were applied while animals
were anaesthetized in order to minimize discomfort. Continuous
general anaesthesia with urethane was used in the pERK experi-
ments because ERK phosphorylation peaks within 5 min after nox-
ious stimulation, and it was therefore necessary to carry out the
perfusion ﬁxation promptly at this time [23].
In order to test for pERK expression during the second phase of
the formalin response [9], 3 rats received a formalin injection in
the foot while under brief isoﬂurane anaesthesia. They were rean-
aesthetized with pentobarbitone and perfused at 30 min after for-
malin injection. This survival time was chosen as it is near the peak
of the second phase, which starts around 15 min after injection
[65,78].
After perfusion ﬁxation, midlumbar (L4–5) segments were re-
moved from all animals and cut into 60-lm-thick sections with a
Vibratome. Transverse sections were used for all parts of the study.
Sections were immersed in 50% ethanol for 30 min, and those
from glutaraldehyde-ﬁxed animals were treated with 1% sodium
borohydride for 30 min (to reduce free aldehyde groups), followed
by extensive rinsing. Sections were then processed for multiple-
labelling immunoﬂuorescent detection, as described below. Details
of the sources and concentrations of primary antibodies are listed
in Table 1. All secondary antibodies were raised in donkey and
were species speciﬁc. Fluorescent secondary antibodies were con-
jugated to Rhodamine Red, DyLight 649 (1:100, 1:500, respec-
tively; both from Jackson Immunoresearch) or Alexa 488 (1:500;
Invitrogen). In some cases, secondary antibodies conjugated to bio-
tin (1:500) or horseradish peroxidase (HRP; 1:1,000, both from
Jackson Immunoresearch) were used. The biotinylated antibodies
were revealed with avidin conjugated to Paciﬁc Blue (1:1,000;
Invitrogen) or with avidin–HRP (Sigma; 1:1,000) followed by tyra-
mide signal ampliﬁcation (TSA; tetramethylrhodamine kit; Perkin-
Elmer Life Sciences). The HRP-labelled secondary antibodies were
revealed with TSA. TSA reactions were used when 2 of the primary
antibodies in an immunoreaction were raised in the same species
(Fos combined with either NPY or galanin). In these cases, the ini-
tial incubation included one of these antibodies at low concentra-
tion (Table 1), and this was revealed with TSA. The sections were
subsequently reacted with the other primary antibody, which
was revealed with secondary antibody conjugated to a different
ﬂuorochrome [3]. For all other reactions sections were initially
incubated in a cocktail containing all primary antibodies and then
in a corresponding mixture of secondary antibodies. Primary anti-
body incubations were for 3 days and those in secondary antibod-
ies were overnight (both at 4C). Antibodies were diluted in PBS
that contained 0.3% Triton-X100, except for reactions involving
anti-sst2A, in which 5% normal donkey serum was included in bothUsed in combination with the TSA (tyramide signal ampliﬁcation) method.
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which the blocking reagent supplied by the manufacturer was
used. All sections were mounted in anti-fade medium and stored
at 20C. In all cases, combinations of 3 or 4 ﬂuorescent dyes with
widely differing emission spectra (eg, Paciﬁc blue, Alexa 488, Rho-
damine Red and DyLight 649) were used.
Unless otherwise stated, sections were selected for scanning
and analysis before immunoﬂuorescence was examined. They
were scanned with a Bio-Rad radiance confocal microscope (with
Argon multi-line, 543 nm HeNe and 637 diode lasers) or a Zeiss
LSM710 confocal (with Argon multi-line, 405 nm diode, 561 nm
solid state and 633 nm HeNe lasers) through 40 oil-immersion
lenses (numerical aperture 1.3) with the pin-hole set to 1 Airy unit.
Overlapping ﬁelds to cover laminae I–III were scanned at 2 lm z
separation through the full thickness of the section, except for
the analysis of GABA immunoreactivity.
All quantitative analyses were carried out with Neurolucida for
Confocal software (Microbrightﬁeld). The outline of the grey mat-
ter and the border between laminae II and III were drawn for the
transverse sections, and the locations of immunoreactive cells
were plotted onto these outlines. The position of the lamina II/III
border was determined either from dark ﬁeld scans, or from the
ventral border of the plexus of sst2A-immunoreactive dendrites
[70]. Although a stereological method was not used for any of
the analyses of cell counts in the z stacks that were obtained from
the full thickness of the sections, the sampling bias towards larger
neurons is likely to have been very small, as the section thickness
(60 lm) was considerably larger than the cell bodies of the neu-
rons that were being sampled.
2.2. Expression of sst2A among different populations of interneurons
Sections from the L4 segments of 3 rats that had been ﬁxed with
4% formaldehyde were reacted with guinea pig anti-sst2A, mouse
monoclonal antibody NeuN [40] and rabbit antibodies against
one of the following: galanin, NPY or parvalbumin. Two sections
were selected from each rat for each antibody combination, and
confocal scans were obtained from laminae I–III on one side for
each section. Initially, only the channels corresponding to NeuN
and either galanin, NPY or parvalbumin were viewed with Neu-
rolucida, and the locations of all neurons that were galanin, NPY
or parvalbumin immunoreactive were plotted. The channel corre-
sponding to sst2A was then viewed, and the presence or absence
of the receptor was noted for each selected neuron.
Because nNOS is found in both inhibitory and excitatory inter-
neurons in the rat [54], we analyzed expression of sst2A by
GABA-immunoreactive neurons that contained nNOS in sections
from animals that had been ﬁxed with glutaraldehyde, which pro-
vides optimal retention of GABA. Sections from L4 of 3 rats ﬁxed
with glutaraldehyde/formaldehyde were reacted with rabbit anti-
GABA, sheep anti-nNOS and guinea pig anti-sst2A. Six or 7 sections
were selected from each of the 3 animals before nNOS immuno-
staining was viewed, and either one or both dorsal horns in these
sections were then scanned with the confocal microscope. In this
way, 7 sets of scans (each corresponding to a single dorsal horn
in one Vibratome section) were obtained from each of the 3 ani-
mals. Because penetration of GABA immunostaining is extremely
limited in Vibratome sections [54,61], only the upper surface of
the section was scanned, at 1 lm z separation. Initially, immuno-
staining for nNOS and GABA were viewed, and all nNOS+/GABA+
neurons for which part of the nucleus appeared at the upper sur-
face of the Vibratome section were plotted. The channel corre-
sponding to sst2A was then viewed and the presence or absence
of immunoreactivity was recorded for each selected neuron. We
also used these sections to conﬁrm the presence of GABA in sst2A
neurons. On 5 of the dorsal horns from each rat, we plotted thelocations of all sst2A+ cells in laminae I–III that were present at
the section surface and then examined these for the presence of
GABA immunoreactivity.
2.3. pERK and Fos after noxious stimulation
Sections from the L4 and the rostral part of the L5 segment from
animals that had received noxious heat, pinch or capsaicin injec-
tion 5 min before perfusion ﬁxation were processed to reveal pERK
together with either galanin and nNOS, or NPY and parvalbumin
(guinea pig antibody). Sections from the animals that had received
formalin injection under urethane anaesthesia were treated in the
same way, except that sst2A was also revealed in conjunction with
galanin and nNOS. For each neurochemical marker, tissue from 4
rats was analysed for pERK. From each rat, 4 sections containing
a relatively large number of pERK cells on the side ipsilateral to
the noxious stimulus were selected and scanned with the confocal
microscope. The region of the superﬁcial dorsal horn that con-
tained pERK cells was identiﬁed and drawn onto the outline of
the dorsal horn. Expression of pERK by individual neurons was
not examined at this stage [68]. All cells within this region that
were immunoreactive for the marker being examined were plot-
ted, and then the presence or absence of pERK in each cell was
recorded.
Sections from the corresponding segments of the rats that had
received noxious stimuli 2 h before ﬁxation were processed to re-
veal Fos together with: (1) NPY and parvalbumin (guinea pig anti-
body), (2) nNOS and sst2A or (3) galanin. The sections reacted to
reveal Fos with nNOS and sst2A were analysed as described above
for pERK, except that 3 sections from each animal were assessed.
Sections reacted for Fos, together with NPY, galanin or parvalbu-
min were examined to determine whether the patterns of Fos
expression were similar to those observed for pERK, but they were
not formally analysed.
Sections from the 3 rats that had received formalin injection un-
der isoﬂurane anaesthesia (30 min survival) were reacted to reveal
pERK, nNOS and sst2A, and 3 sections from each rat were analysed
as described above.
2.4. Antibody characterisation
We have reported that dorsal horn immunostaining with the
galanin and NPY antibodies can be abolished by pretreatment with
the corresponding peptides [51,59], and staining of neurons with
the galanin antibody is absent from the brains of galanin knockout
mice [34]. The nNOS antibody labels a band of 155 kDa in Western
blot tests of rat hypothalamus, and staining is abolished by prein-
cubation with nNOS [17]. The rabbit and guinea pig parvalbumin
antibodies were raised against mouse parvalbumin and recognize
a protein band of the appropriate size on Western blot tests. The
sst2A antibody was raised against the C terminal 15 amino acids
of the peptide sequence of the rat and mouse sst2A receptor, cou-
pled to keyhole limpet haemocyanin. Immunostaining was blocked
by incubation with the peptide antigen (manufacturer’s speciﬁca-
tion). The GABA antibody was raised against GABA conjugated to
porcine thyroglobulin with glutaraldehyde and demonstrated neg-
ligible cross-reactivity against other amino acids (glutamate,
aspartate, glycine or taurine) [48]. The NeuN antibody was raised
against cell nuclei extracted from mouse brain and found to react
with a protein speciﬁc for neurons [40]. We have demonstrated
that NeuN labels all neurons but does not label glial cells in the
rat spinal dorsal horn [70]. The monoclonal antibody against pERK
detects both ERK1 and ERK2 that are dually phosphorylated at
Thr202 and Tyr204 sites, and does not cross-react with either
JNK or p38 MAP kinase that are phosphorylated at the correspond-
ing residues (manufacturer’s speciﬁcation). The Fos antibody was
E. Polgár et al. / PAIN
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Fos. Staining with both pERK and Fos antibodies in the superﬁcial
dorsal horn was restricted to somatotopically appropriate areas
after noxious stimulation.
2.5. Statistical analysis
Kruskall-Wallis 1-way analysis of variance on ranks was used to
compare pERK expression among each of the neurochemical clas-
ses of interneuron after different types of noxious stimulus and
the expression of Fos in response to different noxious stimuli
among the nNOS-immunoreactive cells that expressed sst2A. P val-
ues of <.05 were considered signiﬁcant.
3. Results
3.1. sst2A expression among neurochemical interneuron classes
The distribution of immunostaining for galanin, NPY, parvalbu-
min and sst2A in the formaldehyde-ﬁxed tissue was the same as
that reported previously in the rat [1,28,46,51,59,64,70]. NPY-
immunoreactive cells were distributed throughout lamina I–III,
while galanin-immunoreactive cells were concentrated in lamina
I and the outer part of lamina II (IIo) and present at much lower fre-
quency in the inner part of lamina II (IIi) and lamina III. Parvalbu-
min-immunoreactive cells were largely absent from laminae I and
IIo and were distributed on either side of the lamina II/III border.
sst2A immunoreactivity was present in a dense band that occupied
laminae I and II, and at high magniﬁcation this could be seen as
membrane staining that outlined the cell bodies and dendrites of
some neurons [70]. Occasional sst2A immunoreactive cells were
seen in lamina III. In the glutaraldehyde-ﬁxed sections, the distri-
bution of GABA and nNOS was the same as that described previ-
ously [54], with some cells in each of laminae I–III demonstrating
both types of immunoreactivity. Immunostaining with the sst2A
antibody had the same appearance as that seen in formaldehyde-
ﬁxed tissue.
Quantitative results for this part of the study are provided in Ta-
ble 2, and examples of the immunostaining are illustrated in Fig. 1.
In laminae I–II, sst2A was expressed by the great majority of gala-
nin+ and nNOS+/GABA+ cells (97% and 93%, respectively), but only
by 15% of NPY+ cells and 1% of PV cells. In lamina III, the receptor
was found on 58% of nNOS+/GABA+ cells and a few of the galanin
cells. Between 165 and 184 (mean 174) sst2A+ neurons were iden-
tiﬁed in laminae I–II in sections from the 3 rats ﬁxed with glutar-
aldehyde/formaldehyde, and virtually all of these (mean 99.4%,
range 99.4–99.5%) were GABA immunoreactive, consistent with
our previous ﬁnding in formaldehyde-ﬁxed tissue [70]. In the same
sections the mean number of lamina III sst2A+ cells per rat was 24
(22–25), and 50% (44–56%) of these were GABA-immunoreactive.
Because the restricted penetration of GABA immunostaining meant
that only the superﬁcial parts of the sections could be analysed,
there will be a bias towards larger neurons (which are more likely
to appear at the section surface), and it is therefore not possible toTable 2
Expression of sst2A by different neurochemical types of interneuron in the dorsal horn.a
Laminae I + II
No. counted % sst2A
Galanin 82.3 (69–96) 97.4 (95–10
NPY 107.3 (86–118) 15.5 (11.6–
Parvalbumin 24 (21–26) 1.3 (0–3.8)
nNOS/GABA 35.7 (31–42) 93 (90.3–97
a Data are presented as mean (range) for 3 animals.estimate proportions accurately. However, these results clearly
demonstrate that virtually all sst2A-expressing cells in laminae I
and II are GABAergic, and that the great majority of nNOS+/GABA+
cells express sst2A.
3.2. Responses of interneurons to noxious stimulation
We initially examined expression of pERK among the different
neurochemical cell types in animals that had received pinch, nox-
ious heat or capsaicin injection administered 5 min before ﬁxation
[42]. BecausepERK ismainly seen in laminae I and II after these stim-
uli, we restricted the analysis to cells in this region (Table 3, Fig. 2).
Each of these stimuli gave rise tomany pERK+ cells in the superﬁcial
dorsal hornon the side ipsilateral to the stimulus,with adistribution
similar to that reported in previous studies [23–26,42,72,82]. In all
cases, virtually no pERK+ cells were seen on the contralateral side.
A high proportion of the galanin cells in laminae I and II showed
pERK in response to each of these stimuli (73%, 59% and 43%, respec-
tively, for heat, capsaicin and pinch), while for NPY cells the corre-
sponding values were 52%, 40% and 22%. However, very few nNOS
cells (2–5%) and none of the parvalbumin cells in this region were
pERK+ after these stimuli. Although we did not analyse lamina III,
we noted that none of the parvalbumin cells in this lamina were
pERK+ after any of the stimuli, whereas a few of the NPY and nNOS
cells showed pERK, particularly in response to the pinch stimulus.
Previous studies have reported that some nNOS-containing
neurons in the superﬁcial dorsal horn up-regulate Fos after subcu-
taneous injection of formalin [5,18,31], and we therefore also
examined pERK expression in rats after injection of formalin, in
particular to learn whether the nNOS cells responded speciﬁcally
to this stimulus. However, although we found that pERK was pres-
ent in 68% of galanin and 66% of NPY cells in laminae I–II, only 8%
of the nNOS cells and none of the parvalbumin cells in this region
were pERK+ after formalin injection (Table 3). Analysis of the re-
sponses of the 4 neurochemical populations to these 4 types of
noxious stimulus with Kruskall-Wallis 1-way ANOVA on ranks
demonstrated a signiﬁcant difference between the populations
(P < .001, n = 16 sections). Tukey’s HSD test post hoc revealed that
the proportion of galanin and NPY cells with pERK was signiﬁ-
cantly higher than the proportion of either the nNOS or parvalbu-
min cells (P < .05 in each case). During the course of this study, we
found that most GABAergic nNOS cells in laminae I–II expressed
sst2A, and we therefore used the sst2A antibody on the sections
from formalin-injected rats that were reacted to reveal nNOS. This
allowed us to identify most of the GABAergic nNOS cells in laminae
I–II (ie, those that were sst2A+). Surprisingly, we found that only
1.6% (0–4%) of these showed pERK (Fig. 3a, Table 4).
We therefore tested whether these cells up-regulated Fos 2 h
after formalin injection, even though they had not shown pERK
5 minafter this stimulus. Althoughwedidnot analyse thebehaviour
of these animals, we observed that they demonstrated the expected
2-phase response, with initial licking/ﬂinching of the injected paw
that lasted for 5 min, followed by a prolonged second phase that
started at around 15 min. Again, we used sst2A antibody in order toLamina III
No. counted % sst2A
0) 3.3 (1–5) 8.3 (0–25)
21.2) 35.7 (25–43) 2.1 (0–4)
50.3 (42–59) 0
.6) 15.3 (14–17) 57.6 (35.3–73.3)
Fig. 1. sst2A expression by different neurochemical types of interneuron in lamina II in the rat. (a–c) Two galanin-immunoreactive neurons (arrows) are labelled with the sst2A
antibody, and a sst2A+ cell that lacks galanin is also visible (arrowhead). (d–f) Two NPY-immunoreactive cells (arrows) lack sst2A, which is present on other neurons (2
indicated with arrowheads). (g–i) Two parvalbumin cells are sst2A (arrows) and are located on either side of a sst2A+ neuron (arrowhead). (j–m) A neuron immunoreactive for
both nNOS and GABA is also sst2A+ (double arrow). Two other GABA-immunoreactive neurons that lack nNOS are indicated. One of these (arrow) is sst2A+, while the other
(arrowhead) is sst2A. Several GABA cells (all of which are also sst2A) are present in this ﬁeld, and 3 of these are indicated with asterisks. All images are obtained from single
confocal optical sections. Scale bar (in m) = 20 lm.
Table 3
pERK in different neurochemical types of neuron in laminae I–II.a
Pinch Heat Capsaicin Formalin
No. of cells % pERK No. of cells % pERK No. of cells % pERK No. of cells % pERK
Galanin 39.5 (25–50) 43.1 (33.3–60) 82.5 (61–95) 73.4 (69.7–78.7) 67 (59–81) 59 (48.5–70.4) 62.8 (50–70) 67.7 (57.1–76)
NPY 60.8 (54–67) 21.7 (18.5–23.4) 80 (53–108) 52.3 (48.8–58.3) 88.8 (82–102) 39.8 (37.3–45.1) 89 (73–101) 66.4 (64.9–68.5)
nNOS 150.8 (105–197) 2.4 (1.1–3.4) 191 (151–240) 5.1 (2.5–7.9) 157 (88–207) 4.1 (2.8–5.7) 126 (92–161) 8.3 (4.3–12.4)
Parvalbumin 8.8 (6–12) 0 14.8 (10–18) 0 9.8 (7–15) 0 7.8 (5–9) 0
a Data are presented as mean (range) for 4 animals.
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a very different result because the majority (69%) of nNOS+/sst2A+
cells in laminae I–II were Fos+ (Table 4, Fig. 3e–h) after formalin
injection, although interestingly Fos was present in very few of the
nNOS+/sst2A cells, which correspond largely to nNOS-containing
excitatory interneurons. To testwhether the nNOS+/sst2A+ cellswereselectively activated by formalin, we also looked for Fos expression
after noxious heat and capsaicin injection. Although only 11% of
these cells showed Fos after capsaicin, the majority (73%) were
Fos+ after noxious heat (Table 4). Kruskall-Wallis 1-way ANOVA on
ranks demonstrated a signiﬁcant difference between responses to
thedifferent stimuli (P < .001,n = 9 sections),while post hoc tests re-
Fig. 2. Phosphorylation of ERK in interneurons after noxious stimulation. (a–d) Part of the ipsilateral superﬁcial dorsal horn of the L4 segment from a rat that had undergone
noxious thermal stimulation of one hind paw 5 min previously. This ﬁeld contains 2 neurons that are galanin-immunoreactive (arrows) and 1 that is nNOS immunoreactive
(arrowhead). The 2 galanin cells contain pERK, but the nNOS cell does not. (e–h) A similar ﬁeld from a rat that had received an injection of capsaicin into the ipsilateral hind
paw. This contains a NPY-immunoreactive neuron that contains pERK (arrow) and a parvalbumin (PV) cell that does not (arrowhead). Both images are from single confocal
optical sections. Scale bar (in h) = 20 lm.
Fig. 3. Expression of Fos but not pERK in nNOS-containing inhibitory interneurons after formalin injection. (a–d) A ﬁeld from the L5 segment of a rat that had received an
injection of formalin into the ipsilateral hind paw 5 min previously. Two nNOS-immunoreactive cells that express sst2A (arrowheads) do not show pERK immunoreactivity,
while a nearby sst2A cell that lacks nNOS is pERK+ (arrow). (e–h) A similar ﬁeld from a rat that had received an injection of formalin 2 h previously. Three nNOS+ cells that are
sst2A+ show Fos immunoreactivity (arrows). The cells numbered 1 and 3 show strong nNOS immunostaining, whereas the cell numbered 2 is weakly labelled for nNOS. Both
images are from single confocal optical sections. Scale bar (in h) = 20 lm.
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from those to both heat and formalin (P < .005,Mann-Whitney pair-
wise comparison with Bonferroni correction).Although we did not quantitatively analyse Fos expression
among the other neurochemical populations, this was similar to
the pattern observed with pERK. Many galanin and NPY cells were
Table 4
pERK and Fos expression by nNOS+/sst2A+ cells in laminae I–II after noxious
stimulation.a
Stimulus No. of cells % pERK or Fos
Formalin 5-min survival pERK
(urethane) (n = 4)
32 (24–42) 1.6 (0–4)
Formalin 30-min survival pERK
(isoﬂurane) (n = 3)
29 (26–34) 8 (7.4–8.8)
Formalin 2-h survival Fos (n = 3) 35 (26–41) 68.7 (63.4–76.9)
Heat 2-h survival Fos (n = 3) 29.7 (27–34) 73.4 (55.6–82.4)
Capsaicin 2-h survival Fos (n = 3) 37.3 (34–43) 11.3 (5.7–16.3)
a Data are presented as mean (range) for 3 or 4 animals. All noxious stimuli for
Fos experiments were administered under brief isoﬂurane anaesthesia.
Fig. 4. Estimated sizes of GABAergic interneuron populations in the rat superﬁcial
dorsal horn (laminae I–II). sst2A-expressing (sst2A+) neurons in this region are all
GABAergic and make up just under half of the inhibitory interneurons. This group
contains 2 large populations, which are deﬁned by the presence of galanin or nNOS.
Between them, these account for 60% of the sst2A+ cells. Most NPY-containing cells
lack sst2A, but some express the receptor, and these account for 6% of sst2A+ cells.
Percentages on the pie chart indicate the proportion of all inhibitory interneurons in
laminae I–II that belong to each population. Parvalbumin-containing inhibitory
interneurons are in the set of sst2A cells that lack NPY, but quantitative data are not
available for this population. For further details, see Discussion.
2612 E. Polgár et al. / PAIN

154 (2013) 2606–2615Fos+ after formalin capsaicin or heat, while none of the parvalbu-
min cells showed Fos in response to any of these stimuli.
In order to determine whether the nNOS-containing inhibitory
interneurons phosphorylated ERK during the second phase of the
formalin test, we examined sections from rats that had received
a formalin injection 30 min before perfusion ﬁxation. Although
many pERK cells were seen in laminae I–II in these animals, only
8% of the nNOS+/sst2A+ cells were pERK positive (Table 4).
4. Discussion
The main ﬁndings of this study are: (1) that in laminae I–II sst2A
is expressed by virtually all galanin- and nNOS-containing inhibi-
tory interneurons, but by few NPY cells and not by parvalbumin-
containing cells, (2) that ERK is phosphorylated in many galanin
and NPY cells, but few nNOS cells and no parvalbumin cells after
several types of noxious stimulation, and (3) that nNOS+ inhibitory
interneurons can respond to noxious stimuli because many of
them up-regulate Fos after formalin injection or noxious heat,
although not after capsaicin injection.
4.1. Expression of the sst2A receptor
We have previously reported that in the rat 24.8% and 31.3%,
respectively, of neurons in laminae I and II are GABA immunoreac-
tive [45], while the proportions that express sst2A in these laminae
are 13.3% and 14.6% [70]. We have also demonstrated that there
are7497 lamina I neurons and27,465 lamina II neurons on each
side in the L4 segment [43].We therefore estimate that 29.9%of neu-
rons in the superﬁcial dorsal horn (laminae I–II) are GABAergic and
that 14.3%express sst2A. Because the sst2A-expressing cells in this re-
gion are all GABA immunoreactive (present study and [70]), this
means that they account for approximately half (47.9%) of the inhib-
itory interneurons in this region (Fig. 4). Most inhibitory interneu-
rons that contained galanin or nNOS (97.4% and 93%, respectively)
expressed sst2A, and these 2 populations are non-overlapping [64].
We have previously reported that in lamina I 26.4% of inhibitory
interneurons contain galanin and 16.9% contain nNOS, while for
lamina II the corresponding values are 9.9% (galanin) and 18.7%
(nNOS) [54]. We therefore estimate that the sst2A-expressing gala-
nin and nNOS cells account for 12.5% and 17.1%, respectively, of
the inhibitory interneurons in laminae I–II (corresponding to
26.1% and 35.7% of the sst2A+ cells) (Fig. 4). NPY immunoreactivity
can be detected in 23.4% of GABAergic neurons in lamina I and in
17.3% of those in lamina II [54], and these are different from the cells
that expressnNOSor galanin [28,64].Only16%ofNPY-immunoreac-
tive cells expressed sst2A, and we therefore estimate that the sst2A+
and sst2A NPY cells account for 2.8% and 15.5%, respectively, of
the inhibitory interneurons in laminae I–II (Fig. 4).
nNOS is present in both inhibitory and excitatory interneurons
in laminae I–II [20,54,62], and because most nNOS+/GABA+ neuronsexpress sst2A, immunocytochemical detection of the receptor can
be used to distinguish between these 2 cell types. This avoids the
need to immunostain for GABA, which requires glutaraldehyde ﬁx-
ation for optimal retention. Dynorphin is also expressed by both
inhibitory and excitatory interneurons in the superﬁcial dorsal
horn, with the inhibitory cells corresponding to the galanin popu-
lation [3,4,53]. Immunostaining for sst2A will therefore allow inhib-
itory dynorphin cells to be distinguished from the excitatory ones.
In addition, responsiveness to somatostatin [79] can be used to
identify inhibitory interneurons in patch-clamp recordings from
either nNOS- or dynorphin-expressing cells.
Somatostatin administered intrathecally at physiological con-
centrations has a pro-nociceptive effect [58,73,74], which is
thought to result from hyperpolarization of inhibitory interneu-
rons [79]. The present results indicate that galanin- and/or
nNOS-containing cells in laminae I–II are likely to contribute to this
effect because they account for over half of the sst2A-expressing
cells. The restriction of sst2A to distinct populations of inhibitory
interneurons provides the opportunity for exploring the functions
of these cells by ablating them with a saporin conjugate, as has
been used to investigate the role of other neuronal populations
in the dorsal horn [27,30,35,75].
4.2. Responses to noxious stimulation
There were signiﬁcant differences between inhibitory interneu-
ron populations in their responses to noxious stimulation. Many
galanin and NPY cells were pERK+ after each type of stimulus, indi-
cating that they had been activated. In contrast, very few nNOS
cells and no parvalbumin cells showed pERK in these experiments.
For 3 of the stimuli (pinch, heat, capsaicin), we did not immuno-
stain sections for sst2A, and the nNOS cells that were analysed will
therefore have included both excitatory and inhibitory interneu-
rons. Nonetheless, it was clear that only a very small proportion
of nNOS+ inhibitory interneurons could have phosphorylated ERK,
Fig. 5. Schematic diagram summarizing the inputs to and outputs from the
different interneuron populations. The results of the present study suggest that
many of the galanin and NPY cells are activated by TRPV1-expressing nociceptive
afferents, while the nNOS cells respond to nociceptors that lack TRPV1. These cells
may also receive inputs from non-nociceptive afferents (not shown). Parvalbumin
cells receive synaptic input from myelinated low-threshold mechanoreceptive
(LTM) primary afferents and are probably not innervated by nociceptors. Some
nNOS cells densely innervate giant lamina I projection neurons (I), while the
postsynaptic targets of NPY cells include lamina III projection neurons with the NK1
receptor (III) and excitatory interneurons in lamina II that express PKCc. Note that
the NPY cells may include separate populations that innervate these 2 targets.
Central boutons of low-threshold mechanoreceptive (LTM) afferents are a major
target for the axons of the parvalbumin (PV) cells. Each population has other
postsynaptic targets (represented by question marks), and the targets of the galanin
neurons are not yet known. For further details, see Discussion.
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mals, in which only 2% of nNOS+/sst2A+ cells were pERK+. However,
our ﬁndings with Fos indicate that a high proportion of the nNOS-
containing inhibitory interneurons did respond to formalin and
noxious heat, even though they did not show pERK immunoreac-
tivity after these stimuli. General anaesthesia was maintained
throughout the survival period in most pERK experiments, and this
may have suppressed activation of neurons after noxious stimula-
tion. However, this is unlikely to account for the lack of ERK phos-
phorylation in nNOS neurons, as we have also examined rats that
survived 5 min after formalin injection under brief isoﬂurane
anaesthesia, and found that they seldom showed pERK in nNOS-
containing neurons (A.J. Todd and E. Polgár, unpublished data).
Although ERK phosphorylation is an upstream regulator of Fos
expression in superﬁcial dorsal horn neurons [26], our results sug-
gest that Fos can be induced in the absence of pERK, possibly
through an alternative signalling pathway involving CaMKIV [14].
Previous studies have reported that some inhibitory interneurons
in laminae I–II respond to noxious stimuli [19,69,83,84], but this is
the ﬁrst to demonstrate that these include cells belonging to the gala-
nin andNPYpopulations. Several studies have investigated Fos expres-
sion among nNOS-containing dorsal horn neurons after noxious
stimulation [5,18,29,31,41]. However, these have produced conﬂicting
results. For example, Nazli et al. [41] found very few cells double la-
belled for nNOS and Fos after several types of noxious stimulus (mus-
tard oil, formalin or heat), and Lee et al. reported no double-labelled
cells afternoxiousmechanical stimulation [29]. In contrast, other stud-
ies have reported Fos in signiﬁcant numbers of nNOS-containing neu-
rons after subcutaneous injection of formalin [5,18,31]. Although it is
difﬁcult to reconcile these results, our ﬁndings clearly indicate that a
high proportion of nNOS-containing inhibitory interneurons in lami-
nae I–II can be activated by noxious stimuli.
While many nNOS+ inhibitory interneurons expressed Fos after
heat or formalin, few did so after capsaicin injection, indicating
that capsaicin is a relatively ineffective stimulus for these cells.
Although many nociceptors in the rat and other species express
the capsaicin receptor TRPV1 [71], a signiﬁcant proportion do not
[13,33,38,76]. Our results suggest that TRPV1-lacking nociceptors
may preferentially innervate the nNOS cells, while TRPV1+ noci-
ceptors are involved in activating galanin and NPY cells (Fig. 5).
4.3. Neurochemical populations of inhibitory interneurons
The ﬁnding that NPY-, galanin-, nNOS- and parvalbumin-con-
taining inhibitory interneurons differed in receptor expression pat-
tern and in their responses to noxious stimuli strongly suggests
that these neurochemical markers reveal functionally distinct
populations.
We already know that there are differences in their postsynap-
tic targets (Fig. 5). Two distinct targets for the axons of NPY cells
have been identiﬁed: nociceptive projection neurons in lamina III
that possess the neurokinin 1 receptor (NK1r), and PKCc-express-
ing excitatory interneurons in lamina II [42,46,47]. These axons
are thought to originate from different populations of NPY-con-
taining interneurons [46], and it is possible that these differ in
terms of laminar location and/or sst2A receptor expression. Because
many NPY cells respond to noxious stimulation, those innervating
the lamina III projection neurons may be involved in attenuating
nociceptive inputs to these cells by a mechanism involving feed-
forward inhibition and thus limit the degree of pain felt after a
noxious stimulus [52]. nNOS-containing GABAergic axons, which
are also likely to originate from local inhibitory interneurons,
selectively innervate a population of giant lamina I projection neu-
rons that lack the NK1r [49]. Interestingly, both the giant cells [49]
and the nNOS+ inhibitory interneurons in laminae I–II are activated
by subcutaneous formalin, and nNOS cells may therefore limit theresponses of the giant projection neurons after formalin injection.
Nothing is apparently known about the postsynaptic targets of the
galanin-containing inhibitory interneurons, except that they arbor-
ize mainly in laminae I–IIo [64]. The parvalbumin neurons largely
correspond to islet cells [1,10,12], and their location in laminae III–
III, together with the lack of pERK or Fos expression after various
types of noxious stimulus, is compatible with the suggestion that
they receive low-threshold mechanoreceptive, rather than noci-
ceptive primary afferent input [21]. Hughes et al. have recently
demonstrated that axons of the parvalbumin cells form axo-axonic
synapses onto myelinated low-threshold mechanoreceptors, and
they are therefore likely to generate the surround inhibition neces-
sary for maintaining tactile acuity [21]. It is important to note that
each of these neurochemical classes of inhibitory interneuron may
be further subdivided into distinct populations. It is also likely that
there are additional functional populations still to be identiﬁed
among the inhibitory interneurons that lack galanin, nNOS, NPY
or parvalbumin, and that these will include cells responding to
noxious stimulation.
Ross et al. reported that loss of inhibitory interneurons in mice
lacking the transcription factor Bhlhb5 leads to increased itching
[50].Wehave recently found thatBhlhb5/mice exhibited substan-
tial depletion of both galanin- and nNOS-containing inhibitory
interneurons, but not of NPY or parvalbumin cells (A.J. Todd, E. Pol-
gár and S.E. Ross, unpublished observations). Because many of the
galanin and nNOS cells are activated by noxious stimuli, one or both
of these populationsmay contribute to scratch-mediated inhibition
of itch.
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